InvestorsHub Logo
Followers 8
Posts 2018
Boards Moderated 0
Alias Born 07/19/2006

Re: tregaron post# 34879

Thursday, 11/18/2010 4:15:47 PM

Thursday, November 18, 2010 4:15:47 PM

Post# of 51844
This is really the only serious question. Is there a mechanism to change the 20 cent share price without a reverse split? One way is to obtain good, solid sleep apnea results. ADHD would count to but with the IND filing 'at some future date' I wouldn't put too much stock in timelines. Having adequate funding is another way forward. But to limp forth with a few million, to pay salaries for a few more months, but without enough to do anything on the clinical side? What would be the point?

It is not just about current shareholders. Shouldn't the point be for the technology to move forward?

Look, let them demonstrate something in sleep apnea. This is a major indication and could prove to be a huge windfall for current shareholders. They need a few weeks for data cleanup. Fine. But more distressing for longs is the failure to rapidly come up with an oral form of CX1739, to file an IND for a small scale phase IIa ADHD trial, to rapidly prove proof of principle.

Now we are at the vage whim of "waiting for input" on the trial design by some entity. Whatever that means. Yes. I'm sure the company could fairly easily raise 1.5 to 3 million dollars by printing new warrants with new strike prices, further diluting the company. But it will not advance anything.

One might argue the following for increasing shareholder wealth. 1. let's see what they come up with with sleep apnea. 2. Should this fail or not lead to meaningful pharma interest, can they find away to fund an ADHD trial through a partner or other funding. I will not even get into my jaundiced viewpoint of Cortex being able to rapidly complete said ADHD trial.

But sleep apnea is a flop, or leads to ambiguous, uncertain results which does not elicit pharma interest. And if there is no suitor being able to move the pen onto the paper in the near future to fund an ADHD trial. Might this be a good time to sell the company? Maybe we can get 50 cents for the assets, turning them over to somebody with the money to develop them. It would seem that all parties would benefit.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News